The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland.

IJTLD open Pub Date : 2025-01-01 DOI:10.5588/ijtldopen.24.0357

A Nowinski, E Augustynowicz-Kopeć, J Garnczarek, A Halicka, M Koszela, W Litwiniuk, D Maj, I Mazur, J Niestrój-Ostrowska, R Podlasin, A Regulska, M Wielopolska, J Wyrwiński, S Wesołowski, M Korzeniewska-Koseła

{"title":"The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland.","authors":"A Nowinski, E Augustynowicz-Kopeć, J Garnczarek, A Halicka, M Koszela, W Litwiniuk, D Maj, I Mazur, J Niestrój-Ostrowska, R Podlasin, A Regulska, M Wielopolska, J Wyrwiński, S Wesołowski, M Korzeniewska-Koseła","doi":"10.5588/ijtldopen.24.0357","DOIUrl":null,"url":null,"abstract":"Background: The 2022 invasion of Ukraine by the Russian Federation triggered a refugee crisis, affecting the multidrug-/rifampicin-resistant TB (MDR/RR-TB) prevalence in neighbouring countries. This study examines the epidemiological trends and characteristics of MDR/RR-TB patients in Poland, focusing on the relative contribution of Ukrainian refugees.Methods: Data from the Polish National Tuberculosis Registry and EPIC Project database, covering MDR/RR-TB cases reported between 2010 and Q1 2024, were analysed.Results: The study included 794 MDR/RR-TB cases, showing a demographic shift post-2022. During the 10-year period up to 2021, a median of 48 MDR/RR-TB cases were reported annually in Poland. After 2022, these numbers doubled: 104 cases were reported in 2022 and 101 cases in 2023. Simultaneously, the number of Ukrainian MDR/RR-TB patients increased from 77 (13%) during 2010-2021 to 127 (58%) from 2022 to Q1 2024.Conclusion: Poland is observing an increased number of cases of MDR/RR-TB associated with the large number of displaced Ukrainian citizens who are now residing in Poland. There is a need to monitor the epidemiology of MDR/RR-TB and seek optimal screening and management strategies for TB among refugees from countries with high MDR/RR-TB incidence in Poland and Europe.","PeriodicalId":519984,"journal":{"name":"IJTLD open","volume":"2 1","pages":"6-12"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11724529/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJTLD open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5588/ijtldopen.24.0357","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The 2022 invasion of Ukraine by the Russian Federation triggered a refugee crisis, affecting the multidrug-/rifampicin-resistant TB (MDR/RR-TB) prevalence in neighbouring countries. This study examines the epidemiological trends and characteristics of MDR/RR-TB patients in Poland, focusing on the relative contribution of Ukrainian refugees.

Methods: Data from the Polish National Tuberculosis Registry and EPIC Project database, covering MDR/RR-TB cases reported between 2010 and Q1 2024, were analysed.

Results: The study included 794 MDR/RR-TB cases, showing a demographic shift post-2022. During the 10-year period up to 2021, a median of 48 MDR/RR-TB cases were reported annually in Poland. After 2022, these numbers doubled: 104 cases were reported in 2022 and 101 cases in 2023. Simultaneously, the number of Ukrainian MDR/RR-TB patients increased from 77 (13%) during 2010-2021 to 127 (58%) from 2022 to Q1 2024.

Conclusion: Poland is observing an increased number of cases of MDR/RR-TB associated with the large number of displaced Ukrainian citizens who are now residing in Poland. There is a need to monitor the epidemiology of MDR/RR-TB and seek optimal screening and management strategies for TB among refugees from countries with high MDR/RR-TB incidence in Poland and Europe.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

乌克兰战争对波兰耐多药/耐药结核病流行的影响。

背景：2022年俄罗斯联邦入侵乌克兰引发了一场难民危机，影响了邻国的耐多药/耐利福平肺结核（MDR/RR-TB）发病率。本研究探讨了波兰 MDR/RR-TB 患者的流行病学趋势和特征，重点关注乌克兰难民的相对贡献：方法：分析波兰国家结核病登记处和 EPIC 项目数据库中的数据，涵盖 2010 年至 2024 年第一季度报告的 MDR/RR-TB 病例：研究包括 794 例 MDR/RR-TB 病例，显示出 2022 年后的人口结构变化。在截至 2021 年的 10 年间，波兰每年报告的 MDR/RR-TB 病例中位数为 48 例。2022 年后，这些数字翻了一番：2022 年报告了 104 例，2023 年报告了 101 例。与此同时，乌克兰的 MDR/RR-TB 患者数量从 2010-2021 年间的 77 例（13%）增加到 2022 年至 2024 年第一季度的 127 例（58%）：波兰正在观察到 MDR/RR-TB 病例的增加，这与目前居住在波兰的大量流离失所的乌克兰公民有关。有必要对MDR/RR-TB的流行病学进行监测，并在来自波兰和欧洲MDR/RR-TB高发国家的难民中寻求最佳的结核病筛查和管理策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

IJTLD open

自引率

0.00%

发文量

期刊最新文献

Assessing the accuracy of the updated Fujifilm SILVAMP TB LAM II assay between lot numbers. Closing the gaps in childhood TB detection. Comparative efficacy of tetracyclines against isolates of Mycobacterium avium complex. Efficacy and safety data on pretomanid for drug-resistant TB. Ending the TB epidemic - what can we learn from the HIV epidemic?